Filing Details
- Accession Number:
- 0001725914-19-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-17 12:26:53
- Reporting Period:
- 2019-05-17
- Accepted Time:
- 2019-05-17 12:26:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926617 | Vermillion Inc. | VRML | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1725914 | Harry Robert Beechey | C/O Vermillion, Inc. 12117 Bee Caves Rd Bldg 3-100 Austin TX 78738 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2019-05-17 | 5,000 | $1.26 | 205,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
